Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

X-ray-induced afterglow and radiodynamic therapy tackle the tissue penetration issue of optical imaging and phototherapy. However, inorganic nanophosphors used in this therapy have their radio afterglow dynamic function as always on, limiting the detection specificity and treatment efficacy. Here we report organic luminophores (IDPAs) with near-infrared afterglow and 1O2 production after X-ray irradiation for cancer theranostics. The in vivo radio afterglow of IDPAs is >25.0 times brighter than reported inorganic nanophosphors, whereas the radiodynamic production of 1O2 is >5.7 times higher than commercially available radio sensitizers. The modular structure of IDPAs permits the development of a smart molecular probe that only triggers its radio afterglow dynamic function in the presence of a cancer biomarker. Thus, the probe enables the ultrasensitive detection of a diminutive tumour (0.64 mm) with superb contrast (tumour-to-background ratio of 234) and tumour-specific radiotherapy for brain tumour with molecular precision at low dosage. Our work reveals the molecular guidelines towards organic radio afterglow agents and highlights new opportunities for cancer radio theranostics. © 2023. The Author(s), under exclusive licence to Springer Nature Limited.

Citation

Jingsheng Huang, Lichao Su, Cheng Xu, Xiaoguang Ge, Ruiping Zhang, Jibin Song, Kanyi Pu. Molecular radio afterglow probes for cancer radiodynamic theranostics. Nature materials. 2023 Nov;22(11):1421-1429

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 37667071

View Full Text